Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jeena Sikho LifecareNSE:JSLL +1.18%90 3-Year FCF Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates NSE:JSLL with a GF Score™ of 90/100 and a GF Value™ of ₹805.75 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 467 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks worse than 214132.55% on this metric.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 8 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Jeena Sikho Lifecare was 57.70% per year. The lowest was 34.50% per year. And the median was 46.10% per year.
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Jeena Sikho Lifecare 3-Year FCF Growth Rate Related Terms
NSE:JSLL vs HCA, THC, DVA: 3-Year FCF Growth Rate Comparison
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare 3-Year FCF Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
Jeena Sikho Lifecare (NSE:JSLL) has a 3-Year FCF Growth Rate of 0.00% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Jeena Sikho Lifecare and its competitors. Over the past decade, Jeena Sikho Lifecare's 3-Year FCF Growth Rate has ranged from 34.50 to 57.70. According to the industry distribution chart, Jeena Sikho Lifecare ranks #999999 out of 467 companies in the Healthcare Providers & Services industry.
Is Jeena Sikho Lifecare's 3-Year FCF Growth Rate too high?
Jeena Sikho Lifecare's current 3-Year FCF Growth Rate is 0.00%. Over the past 10 years, this metric has ranged from a low of 34.50 to a high of 57.70. Based on the distribution chart, Jeena Sikho Lifecare ranks #999999 out of 467 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's 3-Year FCF Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #999999 out of 467 companies for 3-Year FCF Growth Rate. This places Jeena Sikho Lifecare in the lower half of its industry. The industry median 3-Year FCF Growth Rate is 12.40. Historically, Jeena Sikho Lifecare's own 3-Year FCF Growth Rate has ranged from 34.50 to 57.70 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Healthcare Providers & Services company?
The median 3-Year FCF Growth Rate among Healthcare Providers & Services companies is 12.40, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year FCF Growth Rate is 12.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current 3-Year FCF Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹805.75, compared to a current price of ₹511.30 — trading 36.5% below its estimated fair value. The current 3-Year FCF Growth Rate is 0.00%. Jeena Sikho Lifecare's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current 3-Year FCF Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹511.30 is trading 36.5% below its estimated GF Value™ of ₹805.75.
GuruFocus considers Jeena Sikho Lifecare to be Significantly Undervalued.
Key valuation signals for NSE:JSLL:
3-Year FCF Growth Rate: 0.00%
GF Value™: ₹805.75 vs. price of ₹511.30 (36.5% below fair value)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
90GF Score
Get the complete analysis for NSE:JSLL
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
